Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Cytori Therapeutics Inc Current Ratio 2006-2019 | PSTV

Cytori Therapeutics Inc current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Cytori Therapeutics Inc Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.01B $0.01B 0.38
2019-03-31 $0.01B $0.02B 0.46
2018-12-31 $0.01B $0.02B 0.55
2018-09-30 $0.01B $0.02B 0.61
2018-06-30 $0.01B $0.02B 0.42
2018-03-31 $0.01B $0.02B 0.60
2017-12-31 $0.02B $0.02B 0.81
2017-09-30 $0.01B $0.02B 0.54
2017-06-30 $0.02B $0.01B 1.18
2017-03-31 $0.01B $0.01B 0.94
2016-12-31 $0.02B $0.01B 1.50
2016-09-30 $0.02B $0.01B 1.93
2016-06-30 $0.03B $0.01B 2.65
2016-03-31 $0.02B $0.01B 1.71
2015-12-31 $0.02B $0.01B 2.52
2015-09-30 $0.03B $0.01B 2.75
2015-06-30 $0.03B $0.01B 3.22
2015-03-31 $0.02B $0.02B 1.06
2014-12-31 $0.02B $0.02B 1.36
2014-09-30 $0.02B $0.01B 1.01
2014-06-30 $0.02B $0.02B 1.23
2014-03-31 $0.02B $0.02B 1.49
2013-12-31 $0.03B $0.02B 1.65
2013-09-30 $0.02B $0.01B 1.43
2013-06-30 $0.02B $0.01B 2.77
2013-03-31 $0.02B $0.02B 1.45
2012-12-31 $0.03B $0.02B 1.93
2012-09-30 $0.02B $0.02B 1.54
2012-06-30 $0.03B $0.01B 2.58
2012-03-31 $0.04B $0.01B 3.68
2011-12-31 $0.04B $0.01B 5.54
2011-09-30 $0.05B $0.01B 7.39
2011-06-30 $0.04B $0.02B 2.59
2011-03-31 $0.05B $0.02B 3.34
2010-12-31 $0.06B $0.01B 4.46
2010-09-30 $0.04B $0.01B 3.79
2010-06-30 $0.04B $0.01B 6.06
2010-03-31 $0.03B $0.01B 4.07
2009-12-31 $0.02B $0.01B 2.21
2009-09-30 $0.02B $0.01B 2.71
2009-06-30 $0.02B $0.01B 2.83
2009-03-31 $0.02B $0.01B 2.86
2008-12-31 $0.02B $0.01B 2.41
2008-09-30 $0.02B $0.01B 2.59
2008-06-30 $0.01B $0.01B 1.10
2008-03-31 $0.01B $0.01B 1.27
2007-12-31 $0.01B $0.01B 1.52
2007-09-30 $0.02B $0.01B 3.53
2007-06-30 $0.03B $0.01B 4.88
2007-03-31 $0.03B $0.01B 4.27
2006-12-31 $0.01B $0.01B 2.12
2006-09-30 $0.02B $0.01B 3.41
2006-06-30 $0.01B $0.01B 2.05
2006-03-31 $0.02B $0.01B 3.13
2005-12-31 $0.02B $0.01B 2.48
2005-09-30 $0.01B $0.01B 2.46
2005-06-30 $0.02B $0.00B 5.13
2005-03-31 $0.01B $0.00B 3.43
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.004B $0.004B
Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $58.854B 36.25
Astellas Pharma (ALPMY) Japan $27.542B 13.12
Takeda Pharmaceutical (TAK) Japan $26.873B 8.39
UCB SA (UCBJF) Belgium $14.267B 0.00
Merck (MKGAF) Germany $14.152B 19.31
Eisai (ESALY) Japan $14.058B 24.17
Grifols, S.A (GRFS) Spain $14.054B 17.93
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.261B 0.00
Ionis Pharmaceuticals (IONS) United States $8.867B 19.12
IPSEN SA ADR (IPSEY) France $8.529B 0.00
Sage Therapeutics (SAGE) United States $8.290B 0.00
Catalent (CTLT) United States $7.406B 29.32
Jazz Pharmaceuticals (JAZZ) Ireland $7.388B 9.72
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.022B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.044B 18.13
United Therapeutics (UTHR) United States $3.692B 0.00
FibroGen (FGEN) United States $3.560B 89.04
Nektar Therapeutics (NKTR) United States $3.523B 0.00
Evotec AG (EVTCY) Germany $3.399B 46.53
Taro Pharmaceutical Industries (TARO) Israel $3.150B 11.29
Tilray (TLRY) Canada $2.976B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.776B 63.65
PTC Therapeutics (PTCT) United States $2.270B 0.00
Portola Pharmaceuticals (PTLA) United States $2.059B 0.00
Xencor (XNCR) United States $2.037B 44.42
Zogenix (ZGNX) United States $1.840B 0.00
Heron Therapeutics (HRTX) United States $1.676B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.553B 15.57
Corcept Therapeutics (CORT) United States $1.548B 21.28
Pacira Pharmaceuticals (PCRX) United States $1.547B 56.30
Ironwood Pharmaceuticals (IRWD) United States $1.505B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.391B 22.95
Radius Health (RDUS) United States $1.320B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.283B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.052B 0.00
Aerie Pharmaceuticals (AERI) United States $0.994B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.975B 4.35
ArQule (ARQL) United States $0.957B 0.00
TherapeuticsMD (TXMD) United States $0.929B 0.00
Endo (ENDP) Ireland $0.874B 1.54
Karyopharm Therapeutics (KPTI) United States $0.725B 0.00
Concordia (CXRXF) Canada $0.681B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.674B 0.00
Lannett Co Inc (LCI) United States $0.566B 5.96
Flexion Therapeutics (FLXN) United States $0.554B 0.00
Akebia Therapeutics (AKBA) United States $0.548B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.544B 0.00
Organogenesis Holdings (ORGO) United States $0.542B 0.00
Translate Bio (TBIO) United States $0.511B 0.00
Aptorum Group (APM) China $0.488B 0.00
ImmunoGen (IMGN) United States $0.472B 0.00
Siga Technologies (SIGA) United States $0.462B 1.08
Innate Pharma SA (IPHYF) France $0.455B 0.00
Indivior (INVVY) United States $0.453B 1.64
Dova Pharmaceuticals (DOVA) United States $0.446B 0.00
Dermira (DERM) United States $0.438B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.428B 19.47
ChemoCentryx (CCXI) United States $0.421B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.416B 0.00
Collegium Pharmaceutical (COLL) United States $0.392B 0.00
DURECT (DRRX) United States $0.372B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.362B 0.00
Harpoon Therapeutics (HARP) United States $0.348B 0.00
OptiNose (OPTN) United States $0.335B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.311B 0.00
Ardelyx (ARDX) United States $0.306B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.293B 0.00
CV Sciences (CVSI) United States $0.289B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.285B 0.00
Rafael Holdings (RFL) United States $0.283B 0.00
Xeris Pharmaceuticals (XERS) United States $0.279B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.274B 0.00
Recro Pharma (REPH) United States $0.263B 0.00
Concert Pharmaceuticals (CNCE) United States $0.262B 0.00
KalVista Pharmaceuticals (KALV) United States $0.258B 0.00
Molecular Templates (MTEM) United States $0.229B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.216B 0.00
Calithera Biosciences (CALA) United States $0.213B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.211B 0.00
Ocular Therapeutix (OCUL) United States $0.203B 0.00
GlycoMimetics (GLYC) United States $0.196B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 31.55
CannTrust Holdings (CTST) Canada $0.180B 0.00
Generex Biotechnology (GNBT) United States $0.176B 0.00
Redhill Biopharma (RDHL) Israel $0.167B 0.00
IMV INC (IMV) Canada $0.164B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
ElectroCore (ECOR) United States $0.141B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.133B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.124B 0.00
Cardiome Pharma (CORV) Canada $0.123B 0.00
Jounce Therapeutics (JNCE) United States $0.113B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Majesco Entertainment (PTE) United States $0.108B 0.00
Mast Therapeutics (SVRA) United States $0.104B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.104B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.099B 0.00
Genocea Biosciences (GNCA) United States $0.094B 0.00
AgeX Therapeutics (AGE) United States $0.090B 0.00
Neos Therapeutics (NEOS) United States $0.090B 0.00
Iterum Therapeutics (ITRM) Ireland $0.089B 0.00
Aquestive Therapeutics (AQST) United States $0.087B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.086B 0.00
RENEURON GP (RNUGF) United Kingdom $0.084B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Nivalis Therapeutics (ALPN) United States $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.077B 29.53
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Natural Alternatives (NAII) United States $0.074B 7.39
Lipocine (LPCN) United States $0.073B 0.00
Novan (NOVN) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.071B 0.00
Jaguar Animal Health (JAGX) United States $0.068B 0.00
Aclaris Therapeutics (ACRS) United States $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Otonomy (OTIC) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.064B 0.00
China SXT Pharmaceuticals (SXTC) China $0.059B 0.00
Capnia (SLNO) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.050B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 1.62
Adamis Pharmaceuticals (ADMP) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Melinta Therapeutics (MLNT) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Opexa Therapeutics (ACER) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
PharmAthene (ALT) United States $0.032B 0.00
Biomerica (BMRA) United States $0.031B 0.00
IsoRay (ISR) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.020B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Vical (BBI) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Onconova Therapeutics (ONTX) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00